236388-59-3

Upstream product

• 236388-69-5 4-Nitro-benzoic acid (S)-2-tert-butoxycarbonylamino-4-((2S,3S,4R,5S,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yl)-butyl ester 
• 793733-69-4 (S)-4-[3-((1R,2R,3R)-2,3-Bis-benzyloxy-1-benzyloxymethyl-pent-4-enyloxy)-but-3-enyl]-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 793733-70-7 (S)-4-[2-((2S,3S,4R,5S,6R)-4,5-Bis-benzyloxy-6-benzyloxymethyl-3-hydroxy-tetrahydro-pyran-2-yl)-ethyl]-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 793733-68-3 (S)-4-[2-((1R,2R,3R)-2,3-Bis-benzyloxy-1-benzyloxymethyl-pent-4-enyloxycarbonyl)-ethyl]-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 302800-64-2 3,4,6-tri-O-benzyl-1,2-dideoxy-D-lyxo-hex-1-enitol 
• 223526-25-8 (4S)-4-(2'-carboxyethyl)-2,2-dimethyloxazolidine-3-carboxylic acid tert-butyl ester 
• 204187-64-4 5,9-anhydro-6,7,8,10-tetra-O-benzyl-2,3,4-trideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-threo-L-galacto-decitol 
• 144542-40-5 5,9-anhydro-6,7,8,10-tetra-O-benzyl-2,3,4-trideoxy-2-(tert-butoxycarbonylamino)-D-threo-L-galacto-decitol 

Downstream Products

• 236388-62-8 3'(S)-N-(tert-butoxycarbonylamino)-4'(R)-nonadec-5'-yn-4'-olyl 2,3,4-tetra-O-benzyl-β-C-D-galactopyranoside 
• 793733-71-8 {(Z)-(S)-1-[2-((2S,3S,4R,5S,6R)-3,4,5-Tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yl)-ethyl]-heptadec-2-enyl}-carbamic acid tert-butyl ester 
• 793733-72-9 (3S,4S,5R)-3-Amino-1-((2S,3S,4R,5S,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yl)-nonadecane-4,5-diol 
• 793733-75-2 {(1S,2S,3R)-2,3-Dihydroxy-1-[2-((2S,3S,4R,5S,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yl)-ethyl]-heptadecyl}-carbamic acid tert-butyl ester 
• 236388-66-2 (3'S,4'R)-3'-amino-(E)-nonadec-5'-en-4'-olyl 2,3,4-tetra-O-benzyl-β-C-D-galactopyranoside 
• 236388-65-1 (3'S,4'R)-3'-aminononadec-5'-yn-4'-olyl 2,3,4-tetra-O-benzyl-β-C-D-galactopyranoside 

Relevant academic research and scientific papers

Synthesis and anti-tumor activity of β-C-glycoside analogs of the immunostimulant KRN7000

A ring-closing metathesis approach was employed for the synthesis of a β-C-glycoside analog of the immunostimulant KRN7000. The protected C-glycosyl amino acid derivative 18 was converted to amino-olefin 20, and osmylation served to install the diol unit

Synthesis of β-D-galactosyl ceramide methylene isostere

The methylene isostere of the glycosphingolipid β-D-galactosyl N- palmitoyl C18 ceramide has been synthesized by a linear reaction sequence starting from a β-linked D-galactopyranosyl aldehyde. First, this sugar aldehyde was converted into a me